With the increased legalization of cannabis, a new unknown emerges for orthopaedic surgeons and their patients. This systematic review aimed to: (1) evaluate complications of cannabis use; (2) determine the effects of cannabis on pain and opioid consumption; and (3) evaluate healthcare utilizations associated with cannabis use among patients undergoing total joint arthroplasty (TJA).
A systematic review was performed. A search of the literature was performed in five databases. We included studies between January 2012 and July 2022 reporting cannabis use and complications, pain management, opioid consumption, length of stay, costs, or functional outcomes following TJA. A meta-analysis of odds ratios (OR) and continuous variables was performed. A total of 19 articles were included in our final analysis.
Cannabis use was associated with higher odds for deep vein thrombosis(DVT) (Odds Ratio(OR): 1.46 [95% Confidence Interval (CI): 1.13-1.89]) and revisions (OR: 1.47 [95% CI: 1.41-1.53]) in total knee arthroplasty(TKA). Cannabis use was associated with similar odds for DVT in total hip arthroplasty(THA) (OR: 1.30 [95% CI: 0.79-2.13]), pulmonary embolus in both TKA (OR: 1.29 [95% CI: 0.95-1.77]), THA (OR: 0.55 [95% CI: 0.09-3.28]), and cardiovascular complications in TKA (OR: 1.97 [95% Cl: 0.93-4.14]). Cannabis use did not alter pain scores, opioid consumption, or cost of care in THA (estimate: $2,550.51 [95% CI: $-356.58-$5,457.62]) but was associated with higher costs in TKA (estimate: $3,552.46 [95%CI: $1,729.71-$5,375.22]). There was no difference in lengths of stay or functional outcomes; however, there may be a potentially increased risk for prosthetic complications, pneumonia, and cerebrovascular accidents among cannabis users.
Cannabis use may be associated with an increased risk of DVTs, revisions, pneumonia, cerebrovascular accidents, and cardiac complications after TJA. Higher-level studies are needed to ascertain the impact of cannabis use for patients undergoing TJA.

Copyright © 2023. Published by Elsevier Inc.